DAF IV EXT CL OL
Report
- Report Number
- 9615050-2008-00281
- Event Type
- Malfunction
- Date Received
- September 23, 2008
- Date of Event
- July 1, 2008
- Report Date
- August 29, 2008
- Manufacturer
- HOSPIRA DE COSTA RICA LTD.
- Product Code
- FPK
- PMA / PMN Number
- PREAMD
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE WAS NOT RETURNED SINCE THIS IS A KNOWN ISSUE. THE ISSUE OF SPLIT OR BURST TUBING WHEN USING POWER INJECTORS WAS EVALUATED UNDER A FORMAL INVESTIGATION. IT WAS DETERMINED THAT THIS IS NOT A MANUFACTURING OR MATERIALS DEFECT. IT WAS COMMUNICATED TO THE CUSTOMER THAT STANDARD I.V. ADMINISTRATION SETS ARE INTENDED FOR GENERAL INFUSION AND NOT RECOMMENDED FOR USE WITH POWER INJECTORS. IN ADDITION, THE INFUSION THERAPY ACCOUNT MANAGERS WERE ADVISED OF THIS ISSUE AND WERE PROVIDED WITH A PRODUCT LIST OF THOSE HIGH-PRESSURE SETS THAT ARE APPROPRIATE FOR USE WITH POWER INJECTORS.
THE CUSTOMER CONTACT REPORTED A TUBING RUPTURE WHILE IN USE WITH A POWER INJECTOR; SUBSEQUENTLY BLEED BACK WAS NOTED. THE TUBING SET WAS BEING USED TO DELIVER AN UNSPECIFIED CONTRAST USING A POWER INJECTOR AT AN UNSPECIFIED RATE. AFTER AN UNSPECIFIED LENGTH OF TIME IN USE, THE TUBING RUPTURED AT AN UNSPECIFIED LOCATION. THE CUSTOMER CONTACT REPORTED AN UNSPECIFIED VOLUME OF BLOOD BACKED UP INTO THE TUBING. THE TUBING SET WAS REPLACED AND THE PROCEDURE WAS COMPLETED. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS. NO MEDICAL INTERVENTIONS WERE REQUIRED. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | DAF IV EXT CL OL | 80-FPK | FPK | HOSPIRA DE COSTA RICA LTD. | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ADULT | UNSPECIFIED CONTRAST MEDIA| UNSPECIFIED POWER INJECTOR |